Assignment task:
Imagine you have a colleague, Remy, who has been taking a narrow-range antibiotic for a gastrointestinal infection. However, this antibiotic does not seem to be successfully treating the infection. Remy's doctor offers to prescribe a different antibiotic that has been shown to kill both bacterial and archaean cells by inhibiting their ribosomes. The doctor warns that this antibiotic is much more likely to have negative side effects. Why is this the case? Select the two best answers. Responses The new antibiotic is more likely to be broken down and destroyed by the actual bacterial species that is causing the infection. The new antibiotic is more likely to be broken down and destroyed by the actual bacterial species that is causing the infection. The new antibiotic is more likely to kill a wide range of Remy's microbiome, which would disrupt Remy's normal physiological processes. The new antibiotic is more likely to kill a wide range of Remy's microbiome, which would disrupt Remy's normal physiological processes. The new antibiotic is more likely to be needed in larger doses in order to successfully treat the infection. The new antibiotic is more likely to be needed in larger doses in order to successfully treat the infection. The new antibiotic is more likely to bind to Remy's ribosomes and cause harm to her cells. Need Assignment Help?